Author

Anton M. Sholukh

Fred Hutch Cancer CenterORCID 0000-0003-0498-9162Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Anton M. Sholukh1 paper

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Callaghan R. GarlandiD· 1 shared Christine JohnstoniD· 1 shared David A. LeibiD· 1 shared Iara M. BackesiD· 1 shared Lesle M JimeneziD· 1 shared Margaret E. AckermaniD· 1 shared Matthew D. SleiniD· 1 shared Natasha S. KelkariD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Callaghan R. GarlandORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyScience Translational MedicinePeer-reviewedNov 19, 2025

Improving antibody-mediated protection against HSV infection by eliminating interactions with the viral Fc receptor gE/gI

Matthew D. Slein, Iara M. Backes, Lesle M Jimenez…·Margaret E. Ackerman

The study shows engineered antibodies lacking Fc receptor binding improve HSV protection, suggesting vaccine strategies targeting IgG3 could enhance immunity.

6 citations

humanbulk RNA-seq

𝕏 PostBluesky